iBio, Inc. (NYSE AMEX:IBIO) recently announced positive interim results from a Phase 1 clinical trial of an iBioLaunch™ platform-produced subunit vaccine directed against Influenza A/California/04/09 (H1N1). The vaccine demonstrated strong induction of dose correlated immune responses, with or without adjuvant, as assessed by virus microneutralization antibody assays and hemagglutination inhibition (HAI) responses. The vaccine was safe and well tolerated at all doses when administered with and without adjuvant.
iBio develops and offers product applications of its iBioLaunch™ platform, providing collaborators full support for turn-key implementation of its technology for both proprietary and biosimilar products.
~~~~~~~~~~~~
Power3 Medical Products, Inc. (PWRM.OB)
Power3 Medical Products, Inc., a leading proteomics company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases, recently announced it has filed several patent applications that are currently pending for its NuroPro technology. PWRM also has a world-wide exclusive license from the Baylor College of Medicine in Houston, Texas. To date, PWRM has given 9 presentations on NuroPro at international scientific meetings in the United States, Europe and China. PWRM has also published 6 articles on NuroPro in peer-reviewed scientific journals. PWRM intends to publish these latest findings as well.
lzheimer’s disease (AD)-also called Alzheimer disease, senile dementia of the Alzheimer type (SDAT), primary degenerative dementia belonging to the Alzheimer’s type (PDDAT), or Alzheimer’s-is often the most typical kind of dementia. This particular incurable, degenerative, and deadly condition was first explained German professional and neuropathologist Alois Alzheimer in 1906 and even was referred to as after him. Generally, it really is determined in individuals over 65 years of age, however the less-prevalent early-onset Alzheimer’s may appear much earlier. In 2006, there have been 26.6 million patients globally. Alzheimer’s is usually expected to influence 1 in 85 people today throughout the world by the year 2050
Alzheimer’s disease has no existing cure, and yet treatment options designed for symptoms can be purchased and research carries on. Despite the fact that most current Alzheimer treatments can’t cease Alzheimer’s disease from moving on, they can in the short term gradual the deterioration involving signs of illness in addition to strengthen well being for anyone with Alzheimer’s disease as well as those caregivers. Right now, there exists a international effort under route to finding possible ways to manage the ailment, postponement its beginning, and stop it from evolving.
PWRM pursues an aggressive intellectual property strategy to protect its inventions and discoveries made on its own and with its collaborators. Power3 Medical works with key physician scientists at major medical research and treatment centers.
With access to decisive human clinical samples and superior trade secret proteomic methodologies, the Company provides solutions to pressing challenges in diagnosis and treatment of patients and has concluded research agreements, technology license agreements, and filed provisional and utility patents.
Power3 is also adding additional layers of research and license agreements, patent filings, and trade secrets, as its technology and product portfolio develops.
PWRM continues to discover new ways to test for Alzheimers, Parkinsons, and Breast Cancer!
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 has developed a portfolio of products including BC-SeraPro, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
To discover more about PWRM visit: http://www.Power3Medical.com
~~~~~~~~~~~~
RELM Wireless Corporation (AMEX:RWC) announced that its KNG Series mobile and portable radios are now Project 25 Compliance Assessment Program (P25 CAP)-validated on the infrastructure of four competitors, and have been included on the Responder Knowledge Base (RKB) website (WWW.RKB.US).
RELM Wireless Corporation engages in the design, manufacture, and marketing of wireless communications products for government and public safety, and business and industrial markets in the United States and internationally.
~~~~~~~~~~~~
Crown Equity Holdings Inc. (CRWE.OB)
Crown Equity Holdings Inc. announces that it has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.
“In addition to publishing to the mentioned countries, Crown Equity Holdings Inc. has also established online publishing sites for over 660 various cities within those countries,” stated Arnulfo Saucedo-Bardan, Chairman of the Board for CRWE.
CRWE has also established over 1,100 city specific sites within the US, allowing CRWE to publish its news and information globally or geographically.
“This increases Crown Equity Holdings Inc. online network, which already receives more than 510,000 pages views per month, during its 357,000 visits from over 250,000 people according to a third party media measurement service provider Quantcast,” stated Kenneth Bosket, President of CRWE.
CRWE’s wholly owned subsidiary, Crown Tele Services Inc., has completed installing servers for its business, which is currently in the process of preparing to provide and offer its “VoIP” communication services to small, large and enterprise businesses.
Crown Equity Holdings Inc. announced recently that its subsidiary company, Crown Tele Services Inc. (http://www.crownteleservices.com) is rolling out its internet based voice and video service IP-PBX solutions this year.
The cornerstone of Crown Tele Services Inc. strategy is to meet the highest standards when it comes to delivering VoIP (Voice over Internet Protocol) communication solutions specifically designed to meet the market needs.
Crown TeleServices Services
Crown TeleServices assume responsibility for the entire implementation, freeing you to concentrate on other priorities and helping to ensure that system deployment goes flawlessly; on time and on budget.
Design & Integration to Implementation Services
From assessment and design to integration to installation, as well as consulting and training to ongoing maintenance, across Mobility & Unified Communications, Security, Voice & Video, Contact Centers and Networks. Crown TeleServices Implementation Services help ensure your system is deployed for optimum performance and satisfaction.
Including:
- Least-cost routing for outbound telephone calls to reduce long-distance charges
- 911 call-routing design to ensure the correct first responder is called and accurate information is delivered
- Complex call routing requirement
- Disaster recovery plan and support
- Long-term capacity planning
After all, the backbone of any successful communication system deployment is a sound design.
Crown TeleServices is the provider of simple Unified Communications (UC) solutions based for the IP business phone system.
Crown TeleServices delivers a system designed to be as easily managed as it is to deploy and use.
Along with its low total cost of ownership, a Crown TeleServices UC system helps organizations leverage their most valuable assets: people and information.
Crown Equity Holdings Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. CRWE offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
To discover more about CRWE visit: http://www.crownequityholdings.com
~~~~~~~~~~~~
Claude Resources Inc. (AMEX:CGR) reported its first quarter financial and operating results. For the quarter ended March 31, 2011, the Company recorded a net profit of $1.8 million, or $0.01 per share. This compares to a net loss of $1.6 million for the comparable period in 2010, or $0.01 per share.
Claude Resources Inc. engages in the acquisition, exploration, and development of precious metal properties, as well as production and marketing of minerals in Canada.
*************************************************************
For FREE Daily Stock Alerts & Updates Signup At: http://pennytobuck.com/signup
*************************************************************
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PennyToBuck.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers.Our disclaimer (http://pennytobuck.com/disclaimer) is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold PennyToBuck.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
